Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
0(0%)
Results Posted
45%(5 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
1
8%
Ph not_applicable
1
8%
Ph phase_1
6
50%
Ph phase_4
4
33%

Phase Distribution

6

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
6(50.0%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 4Post-market surveillance
4(33.3%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(11)
Terminated(1)

Detailed Status

Completed11
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (50.0%)
Phase 21 (8.3%)
Phase 44 (33.3%)
N/A1 (8.3%)

Trials by Status

completed1192%
terminated18%

Recent Activity

0 active trials
Showing 5 of 12
completednot_applicable

Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)

NCT02473042
completedphase_1

Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions

NCT00934180
completedphase_1

Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions

NCT00934921
terminatedphase_4

PROUD Study - Preventing Opioid Use Disorders

NCT04766996
completedphase_1

Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran

NCT03973047
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT02473042Not Applicable

Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)

Completed
NCT00934180Phase 1

Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions

Completed
NCT00934921Phase 1

Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions

Completed
NCT04766996Phase 4

PROUD Study - Preventing Opioid Use Disorders

Terminated
NCT03973047Phase 1

Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran

Completed
NCT03254459Phase 2

Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain

Completed
NCT02110719Phase 4

Decreasing Narcotics in Advanced Pelvic Surgery

Completed
NCT01953978Phase 4

The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen on Postoperative Pain After Spine Surgery

Completed
NCT01933542Phase 4

The Effect of Chlorzoxazone on Moderate to Severe Postoperative Pain After Spine Surgery

Completed
NCT00659074Phase 1

Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions

Completed
NCT00654277Phase 1

Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions

Completed
NCT00653458Phase 1

Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12